These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14180121)

  • 1. [PATHOGENESIS OF THE BASIC SYMPTOMS OF PARKINSONISM DUE TO BIOCHEMICAL CHANGES IN THE SUBCORTICAL AND STEM STRUCTURES OF THE EXTRAPYRAMIDAL SYSTEM].
    TRAVENEC I
    Cas Lek Cesk; 1964 Jun; 103():748-52. PubMed ID: 14180121
    [No Abstract]   [Full Text] [Related]  

  • 2. [PATHOGENESIS OF THE BASIC SYMPTOMS OF PARKINSONISM DUE TO BIOCHEMICAL CHANGES IN THE SUBCORTICAL AND STEM STRUCTURES OF THE EXTRAPYRAMIDAL SYSTEM].
    TRAVENED I
    Cas Lek Cesk; 1964 Jun; 103():748-52. PubMed ID: 14178689
    [No Abstract]   [Full Text] [Related]  

  • 3. ADMINISTRATION OF DIHYDROXYPHENYLALANINE TO PARKINSONIAN PATIENTS.
    MCGEER PL; ZELDOWICZ LR
    Can Med Assoc J; 1964 Feb; 90(7):463-6. PubMed ID: 14120951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ON THE CONTROL OF AKINESIA AND OTHER EXTRAPYRAMIDAL MOTOR DISORDERS WITH L-DOPA (L-DIHYDROXYPHENYLALANINE)].
    HIRSCHMANN J; MAYER K
    Dtsch Med Wochenschr; 1964 Oct; 89():1877-80. PubMed ID: 14211843
    [No Abstract]   [Full Text] [Related]  

  • 5. [NEW MEANS OF CONTROLLING EXTRAPYRAMIDAL MOTOR DISORDERS].
    HIRSCHMANN J; MAYER K
    Arzneimittelforschung; 1964 Jun; 14():SUPPL:599-601. PubMed ID: 14253979
    [No Abstract]   [Full Text] [Related]  

  • 6. [Disturbances of catecholamine metabolism (with special reference to dopamine) in the Parkinsonian syndrome].
    Tissot R
    Presse Med (1893); 1969 Apr; 77(17):617-8. PubMed ID: 5785080
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current treatment of Parkinson syndrome with L-dopa].
    Gerstendbrand F; Gründig E; Musiol A
    Pol Tyg Lek; 1972 May; 27(21):798-800. PubMed ID: 4555002
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dopaminergic conception of Parkinsonism and its treatment with L-DOPA].
    Levin SL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(9):1418-26. PubMed ID: 4349303
    [No Abstract]   [Full Text] [Related]  

  • 9. BIOCHEMICAL ASPECTS OF COPPER AND AROMATIC AMINES IN RELATION TO THE EXTRAPYRAMIDAL SYSTEM.
    WALAAS E; WALAAS O
    Acta Neurol Scand Suppl; 1963; 39(4):SUPPL4:84-94. PubMed ID: 14057524
    [No Abstract]   [Full Text] [Related]  

  • 10. [Stereotactic brain operations for the treatment of extrapyramidal movement disorders (parkinsonism and hyperkinesias) and their results].
    MUNDINGER F; RIECHERT T
    Fortschr Neurol Psychiatr Grenzgeb; 1963 Jan; 31():1-65 contd. PubMed ID: 13936606
    [No Abstract]   [Full Text] [Related]  

  • 11. [The stereotactic brain operations for the treatment of extrapyramidal movement disorders (parkinsonism and hyperkinesias) and their results].
    MUNDINGER F; RIECHERT T
    Fortschr Neurol Psychiatr Grenzgeb; 1963 Feb; 31():69-120 concl. PubMed ID: 13936605
    [No Abstract]   [Full Text] [Related]  

  • 12. THE CLASSIFICATION OF THE DISEASES OF THE EXTRAPYRAMIDAL SYSTEM.
    BAUMANN J
    Acta Neurol Scand Suppl; 1963; 39(4):SUPPL4:102-7. PubMed ID: 14057495
    [No Abstract]   [Full Text] [Related]  

  • 13. ELECTROPHYSIOLOGICAL STUDIES IN STEREOTAXIC SURGERY FOR EXTRAPYRAMIDAL DISORDERS. 3. MECHANISM OF PARKINSONIAN TREMOR.
    JINNAI D; NISHIMOTO A; NUMOTO M; ADACHI I
    Confin Neurol; 1964; 24():289-300. PubMed ID: 14204909
    [No Abstract]   [Full Text] [Related]  

  • 14. [THE BEHAVIOR OF BRAIN ENZYMES IN DISEASES OF THE EXTRAPYRAMIDAL MOTOR SYSTEM].
    HARTMANN-VONMONAKOW K
    Schweiz Arch Neurol Neurochir Psychiatr; 1963; 92():415-6. PubMed ID: 14059163
    [No Abstract]   [Full Text] [Related]  

  • 15. [SURGERY OF THE EXTRAPYRAMIDAL TRACTS AND THE DIENCEPHALON].
    SANO K
    Nihon Ishikai Zasshi; 1964 Dec; 52():1217-38. PubMed ID: 14288395
    [No Abstract]   [Full Text] [Related]  

  • 16. [Progress in the therapy of parkinsonism with L-dopa: inhibition of dopa decarboxylase].
    Nurzia A
    Clin Ter; 1975 Feb; 72(3):289-95. PubMed ID: 1132216
    [No Abstract]   [Full Text] [Related]  

  • 17. [FLUOTHANE IN STEREOTACTIC SURGERY OF THE EXTRAPYRAMIDAL SYSTEM].
    BIANCHETTI L; URCIUOLI R
    Minerva Anestesiol; 1963 Aug; 29():311-2. PubMed ID: 14083375
    [No Abstract]   [Full Text] [Related]  

  • 18. L-dopa therapy in parkinsonism: mechanism of action.
    Sandler M
    Psychiatr Neurol Neurochir; 1971; 74(4):331-3. PubMed ID: 5146239
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the problem of the metabolism of dopamine in the brain of patients with parkinsonism].
    Travenets IA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(10):1505-7. PubMed ID: 6000312
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical results with artane in parkinsonism and other extrapyramidal syndromes].
    GOEBEL U
    Munch Med Wochenschr; 1951 May; 93(21):1082-4. PubMed ID: 14843087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.